Skip to main content
Market intelligence
EBSHealthcare

Emergent Biosolutions Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
May 1, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
May 1, 2026Kathryn C ZoonCorporate insiderSale17,202$8.40$144,454
May 1, 2026Donald W DeGolyerCorporate insiderSale15,481$8.40$129,994
May 1, 2026Sujata Tyagi DayalCorporate insiderSale13,761$8.40$115,610